Moderna will increase its deliveries to 1.33 million doses a week in July from 733,000 previously expected, raising the figure to 2.57 million a week in August and 2.95 million a week in September, the ministry said.
The FDA granted donanemab a breakthrough therapy designation, meant to expedite the development and review of medicines for serious or life-threatening conditions.
The joint announcement by AstraZeneca and Siam Bioscience, a firm owned by Thailand's king, comes amid public anxiety about vaccine supplies, as the country suffers its most severe outbreak so far.
It did not say whether the Thai plant would make all 6 million doses that Thailand's government has promised would be available this month.
"This has been driven by several factors, including significant reductions in cases in the US and other major developed countries, accelerated rollout of COVID-19 vaccines globally and, most recently, US health authority guidance on testing for fully vaccinated individuals," the drugmaker said.
Abbott sees second-quarter adjusted profit from continuing operations of at least $1 per share, compared with analysts' estimates of $1.23 per share.
Nearly 30% of the US population has been vaccinated against COVID-19, hitting demand for antibody drugs that already suffered from slower-than-expected uptake by hospitals.
Sales of other high-profile Lilly drugs also fell short of Wall Street expectations and its shares fell 3% to $181.64 in morning trading.
The Department of Health and Human Services facilitated the move, the health official said in an email, asking not to be named due to the sensitivity of the matter.
Brazil's health ministry registered a record 3,251 fatalities in 24 hours, bringing the country's overall death toll to nearly 299,000 -- second only to the United States.